JP2016517390A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016517390A5 JP2016517390A5 JP2015555403A JP2015555403A JP2016517390A5 JP 2016517390 A5 JP2016517390 A5 JP 2016517390A5 JP 2015555403 A JP2015555403 A JP 2015555403A JP 2015555403 A JP2015555403 A JP 2015555403A JP 2016517390 A5 JP2016517390 A5 JP 2016517390A5
- Authority
- JP
- Japan
- Prior art keywords
- buffer
- heparinoid
- acid
- tris
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361757592P | 2013-01-28 | 2013-01-28 | |
| US61/757,592 | 2013-01-28 | ||
| PCT/US2014/013352 WO2014171986A1 (en) | 2013-01-28 | 2014-01-28 | Stable compositions comprising heparinoid, acute-acting anesthetic, and buffer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018152223A Division JP2019006783A (ja) | 2013-01-28 | 2018-08-13 | ヘパリノイド、即時作用性麻酔薬、及び緩衝液を含む安定組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016517390A JP2016517390A (ja) | 2016-06-16 |
| JP2016517390A5 true JP2016517390A5 (enExample) | 2017-03-02 |
Family
ID=51731742
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015555403A Pending JP2016517390A (ja) | 2013-01-28 | 2014-01-28 | ヘパリノイド、即時作用性麻酔薬、及び緩衝液を含む安定組成物 |
| JP2018152223A Pending JP2019006783A (ja) | 2013-01-28 | 2018-08-13 | ヘパリノイド、即時作用性麻酔薬、及び緩衝液を含む安定組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018152223A Pending JP2019006783A (ja) | 2013-01-28 | 2018-08-13 | ヘパリノイド、即時作用性麻酔薬、及び緩衝液を含む安定組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20150359816A1 (enExample) |
| EP (1) | EP2948154A4 (enExample) |
| JP (2) | JP2016517390A (enExample) |
| KR (1) | KR20160008496A (enExample) |
| CN (1) | CN105263503A (enExample) |
| AU (2) | AU2014254472A1 (enExample) |
| BR (1) | BR112015018047A8 (enExample) |
| CA (1) | CA2899636C (enExample) |
| IL (1) | IL240194B (enExample) |
| MX (1) | MX2015009696A (enExample) |
| SG (1) | SG11201505853RA (enExample) |
| WO (1) | WO2014171986A1 (enExample) |
| ZA (1) | ZA201505814B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10117847B2 (en) * | 2015-12-04 | 2018-11-06 | Ventis Pharma | Extended duration local anesthetic formulation |
| CA3090767A1 (en) | 2017-02-27 | 2018-08-30 | Urigen N.A. | Treatment of lower urinary tract epithelium with glucagon like peptide 2 |
| CN111787915A (zh) | 2017-04-12 | 2020-10-16 | 尤里根制药股份有限公司 | 注射器中包含局部麻醉剂、缓冲剂和糖胺聚糖的稳定性提高的制品 |
| EP3400951B1 (de) * | 2017-05-12 | 2019-12-11 | Farco-Pharma GmbH | Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (4,5 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis |
| EP3415163B1 (de) * | 2017-06-13 | 2023-02-22 | Farco-Pharma GmbH | Zusammensetzung mit lokalanästhetischer wirkung und deren verwendung |
| ES2968164T3 (es) * | 2019-04-26 | 2024-05-08 | Tcm Biotech Int Corp | Composición farmacéutica para la prevención de infección urinaria recurrente |
| TWI887239B (zh) * | 2019-05-17 | 2025-06-21 | 日商半導體能源研究所股份有限公司 | 發光元件、發光裝置、電子機器及照明裝置 |
| AU2020315353A1 (en) | 2019-07-18 | 2022-03-10 | C. Lowell Parsons | Alkalization of urinary bladder wall prior to treatment with intravesical heparin and alkalinized lidocaine to enhance relief of bladder pain symptoms |
| CN115814099B (zh) * | 2022-12-19 | 2024-04-26 | 成都蓉生药业有限责任公司 | 一种人凝血因子ix的干热处理稳定剂及其制剂与制备方法 |
| MX2023012862A (es) * | 2023-10-27 | 2023-11-09 | Mar Mariana Guerrero | Composicion topica de agentes esclerosantes en portadores acuosos. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5603695A (en) * | 1995-06-07 | 1997-02-18 | Erickson; Kim | Device for alkalizing local anesthetic injection medication |
| SI1708722T1 (sl) * | 2004-01-28 | 2014-10-30 | The Regents Of The University Of California | Nova intersticijska terapija za takojšnje simptome sprostitve in kronična terapija pri intersticijskem cistitisu |
| EP2839830B1 (en) * | 2005-01-14 | 2019-05-15 | Urigen, Inc. | Kits and compositions for treating lower urinary tract disorders |
| WO2007073397A1 (en) * | 2005-12-19 | 2007-06-28 | Urigen, Inc. | Kits and improved compositions for treating lower urinary tract discorders |
| US8357795B2 (en) * | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
| ES2634505T3 (es) * | 2009-08-13 | 2017-09-28 | Lubris Llc | Tratamiento de PRG4 para la cistitis intersticial |
| US20140194380A1 (en) * | 2011-01-06 | 2014-07-10 | Lowell C. Parsons | Method of manufacturing composition comprising local anesthetic, heparinoid, and buffer |
| US9486747B2 (en) * | 2014-08-12 | 2016-11-08 | The Curators Of The University Of Missouri | Nanocomposite membranes with advanced antifouling properties under visible light irradiation |
-
2014
- 2014-01-28 EP EP14785471.5A patent/EP2948154A4/en not_active Ceased
- 2014-01-28 JP JP2015555403A patent/JP2016517390A/ja active Pending
- 2014-01-28 BR BR112015018047A patent/BR112015018047A8/pt not_active Application Discontinuation
- 2014-01-28 US US14/763,369 patent/US20150359816A1/en not_active Abandoned
- 2014-01-28 AU AU2014254472A patent/AU2014254472A1/en not_active Abandoned
- 2014-01-28 MX MX2015009696A patent/MX2015009696A/es unknown
- 2014-01-28 KR KR1020157023381A patent/KR20160008496A/ko not_active Ceased
- 2014-01-28 SG SG11201505853RA patent/SG11201505853RA/en unknown
- 2014-01-28 CA CA2899636A patent/CA2899636C/en active Active
- 2014-01-28 WO PCT/US2014/013352 patent/WO2014171986A1/en not_active Ceased
- 2014-01-28 CN CN201480018245.5A patent/CN105263503A/zh active Pending
-
2015
- 2015-07-28 IL IL240194A patent/IL240194B/en unknown
- 2015-08-13 ZA ZA2015/05814A patent/ZA201505814B/en unknown
-
2018
- 2018-08-13 JP JP2018152223A patent/JP2019006783A/ja active Pending
- 2018-10-11 AU AU2018247284A patent/AU2018247284A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016517390A5 (enExample) | ||
| JP2004532217A5 (enExample) | ||
| ECSP088903A (es) | Composiciones farmacéuticas de anticuerpo antagonista anti-cd40 | |
| EA200801776A1 (ru) | Гидразиды миндальной кислоты | |
| CA2438544A1 (en) | Aerosol compositions containing formoterol for delivery to the lungs via nebulization | |
| RU2013141845A (ru) | Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа | |
| JP2012224636A5 (enExample) | ||
| NO20080357L (no) | Farmasoytiske sammensetninger for modifisert avgivelse, samt fremgangsmater for fremstilling av samme | |
| RU2012153786A (ru) | Стабильные многодозовые композиции, содержащие антитело и консервант | |
| BR112014009910A2 (pt) | formulações de sal de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico | |
| JP2017061503A (ja) | 局所麻酔剤、ヘパリノイド、及び緩衝剤を含む組成物を製造する方法 | |
| KR20160008496A (ko) | 헤파리노이드, 급성 작용성 마취제 및 버퍼를 포함하는 안정한 조성물 | |
| JOP20200314A1 (ar) | تركيبات صيدلانية مستقرة لأجهزة إستنشاق جرعات مضغوطة معايرة الجرعة | |
| PH12015500864A1 (en) | Liquid formulation comprising gm-csf neutralizing compound | |
| CA3064788A1 (en) | Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections | |
| JP2017502278A5 (enExample) | ||
| RU2011147186A (ru) | 2, 5-дизамещенные арилсульфонамидные антагонисты ссr3 | |
| AR085059A1 (es) | Composicion resistente a la corrosion y farmaceuticamente estable para inhalador presurizado de dosis medida y metodo para generarla | |
| CN104402126B (zh) | 一种油田专用杀菌缓蚀剂 | |
| NZ732509A (en) | Method for manufacturing composition comprising local anesthetic, heparinoid, and buffer | |
| NZ732509B2 (en) | Method for manufacturing composition comprising local anesthetic, heparinoid, and buffer | |
| Akhtardanesh et al. | Evaluation of haematological and biochemical changes after short term tramadol usage in healthy dogs. | |
| BR112013025105A2 (pt) | sal de ácido benzoico de otamixaban | |
| WO2009141786A3 (en) | Anti-inflammatory compounds | |
| Joseph et al. | Role Of Caveolin-1 In Silica-Induced Injury In The Mouse Lung |